Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study.

International journal of geriatric psychiatry - 1 May 2016

Eyre Harris A, Eskin Ascia, Nelson Stanley F, St Cyr Natalie M, Siddarth Prabha, Baune Bernhard T, Lavretsky Helen

Abstract excerpt

OBJECTIVE: This first pilot study of genome-wide expression as predictor of antidepressant response in late-life depression examined genome-wide transcriptional profiles in a randomized placebo-controlled trial of combined methylphenidate and citalopram. METHODS: Genome-wide transcriptional profiles were examined in peripheral blood leukocytes sampled at baseline and 16 weeks from 35 older adults with major...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Citalopram

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Dopamine Uptake Inhibitors

Share to Induction Chemotherapy

Share to Methylphenidate

Share to Pilot Projects

Share to Psychiatric Status Rating Scales

Source

Open in PubMed Open full text

Identifiers

PMID: 26471432
DOI: 10.1002/gps.4356
PMCID: PMC5567872

Genes

SELENBP1
SNCA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study.PMID 26471432Read ↗

Are there meaningful biomarkers of treatment response for depression?Semantic proximity Read ↗

Genetic Markers for Later Remission in Response to Early Improvement of Antidepressants.Semantic proximity Read ↗

Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.Semantic proximity Read ↗

Individualized Treatment Strategy for Depressive Disorder.Semantic proximity Read ↗

Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression.Semantic proximity Read ↗

Folate metabolism genes, dietary folate and response to antidepressant medications in late-life depression.Semantic proximity Read ↗

Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study.Semantic proximity Read ↗

A genomewide association study of citalopram response in major depressive disorder.Semantic proximity Read ↗

A brain-enriched circRNA blood biomarker can predict response to SSRI antidepressantsSemantic proximity Read ↗

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant responseSemantic proximity Read ↗

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.Semantic proximity Read ↗

Trans-ancestry genome-wide association meta-analysis of antidepressant response to selective serotonin reuptake inhibitors in clinical studies of depressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.